FDA Approves First ProAir HFA Generic

March 4, 2020

FDA Approves First ProAir HFA Generic

The U.S. FDA has announced its approval of the first generic of ProAir HFA (albuterol sulfate), one of the most commonly used metered-dose rescue inhalers. Generating similar generic copies of complex drugs on the market will help get these life-saving drugs into patients’ hands at lower costs. With all of the cost pressures affecting patients and the industry today, Yourway is enthusiastic about any measures that reduce healthcare costs.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Pharma Supply Chain & Logistics Innovation Programme EU

May 20-21, 2026
Basel, Switzerland

Schedule a Meeting

Clinical Trial Supply West Coast

September 22-23, 2026
Burlingame, CA

Schedule a Meeting

Media

Articles

Global Reach in Clinical Trials: Beyond Presence to True Execution

Open chat

Hello! How can I help you?